HIV-1 pol mutation frequency by subtype and treatment experience: extension of the HIVseq program to seven non-B subtypes

AIDS
Soo-Yon RheeInternational Non Subtype B HIV-1 Working Group

Abstract

HIVseq was developed in 2000 to make published data on the frequency of HIV-1 group M protease and reverse transcriptase (RT) mutations available in real time to laboratories and researchers sequencing these genes. Because most published protease and RT sequences belonged to subtype B, the initial version of HIVseq was based on this subtype. As additional non-B sequences from persons with well-characterized antiretroviral treatment histories have become available, the program has been extended to subtypes A, C, D, F, G, CRF01, and CRF02. The latest frequency of each protease and RT mutation according to subtype and drug-class exposure was calculated using published sequences in the Stanford HIV RT and Protease Sequence Database. Each mutation was hyperlinked to published reports of viruses containing the mutation. As of September 2005, the mean number of protease sequences per non-B subtype was 534 from protease inhibitor-naive persons and 133 from protease inhibitor-treated persons, representing 13.2% and 2.3%, respectively, of the data available for subtype B. The mean number of RT sequences per non-B subtype was 373 from RT inhibitor-naive persons and 288 from RT inhibitor-treated persons, representing 17.9% and 3.8%, respec...Continue Reading

References

Jan 10, 2003·Nucleic Acids Research·Soo-Yon RheeRobert W Shafer
Apr 3, 2004·AIDS·Zehava GrossmanUNKNOWN Israel AIDS Multi-Center Study Group

❮ Previous
Next ❯

Citations

Feb 1, 2007·AIDS Research and Human Retroviruses·Nicole VidalMartine Peeters
Oct 22, 2009·AIDS Research and Human Retroviruses·Carmen De MendozaVincent Soriano
Oct 19, 2010·AIDS Research and Human Retroviruses·Vijay BansodeGrace P McCormack
Aug 9, 2011·AIDS Research and Human Retroviruses·Jaime SoriaLisa Frenkel
Mar 6, 2013·AIDS Research and Human Retroviruses·Andres H RossiPaula C Aulicino
Apr 4, 2012·Journal of Computational Biology : a Journal of Computational Molecular Cell Biology·Nimrod Bar-YaakovNathan Intrator
Nov 14, 2012·The Journal of Infectious Diseases·Katie MollanUNKNOWN AIDS Clinical Trials Group Study A5202 Team
Feb 7, 2013·The Journal of Antimicrobial Chemotherapy·F A KoningUNKNOWN UK Collaborative Group on HIV Drug Resistance
Feb 16, 2007·AIDS·Patricia A CaneUNKNOWN UK collaborative group on HIV Drug Resistance
Nov 1, 2006·Current Opinion in Infectious Diseases·Rami Kantor
Mar 16, 2011·Antimicrobial Agents and Chemotherapy·Kimberly L ArmstrongM Essex
Oct 6, 2009·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Carole L WallisWendy Stevens
Mar 1, 2007·Current Opinion in HIV and AIDS·Bluma G Brenner
Dec 30, 2014·Haemophilia : the Official Journal of the World Federation of Hemophilia·B-R KimY-K Cho
Feb 24, 2015·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·K TheysUNKNOWN Portuguese HIV-1 Resistance Study Group
May 11, 2013·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Andrea-Clemencia Pineda-PeñaAnne-Mieke Vandamme
Jul 2, 2009·Journal of the International AIDS Society·Jorge L Martinez-CajasMark A Wainberg
Jan 7, 2015·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Jintanat AnanworanichNittaya Phanuphak
Oct 19, 2016·AIDS·Guillemette UnalUNKNOWN RES-O Surveillance Network
Sep 19, 2008·International Journal of Epidemiology·Niels ObelHenrik T Sørensen
Dec 12, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Trevor A CrowellUNKNOWN RV254/SEARCH010 Study Group
Nov 3, 2016·Journal of the International AIDS Society·Donn J ColbyUNKNOWN Search 010/RV 254 Study Group
Sep 18, 2016·Journal of the International AIDS Society·Trevor A CrowellUNKNOWN RV254/SEARCH010 Study Group
Jan 31, 2012·Intervirology·Michele W TangRobert W Shafer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.